Evidence map›Paper›PMID 33543265›Full record

ArticleNeuro-oncology2021

Longitudinal change in fine motor skills after brain radiotherapy and in vivo imaging biomarkers associated with decline.

Mia Salans, Michelle D Tibbs, Roshan Karunamuni, Anthony Yip, Minh-Phuong Huynh-Le, Anna Christina Macari, Anny Reyes, Kathryn Tringale, Carrie R McDonald, Jona A Hattangadi-Gluth

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Neuro-oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05576103 (Longitudinal Prospective Study of Neurocognitive Outcomes and Multimodal Quantitative Neuroimaging Outcomes in Primary Brain Tumor Patients Receiving Brain Radiotherapy), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05576103 recruitingnot on this map

Longitudinal Prospective Study of Neurocognitive Outcomes and Multimodal Quantitative Neuroimaging Outcomes in Primary Brain Tumor Patients Receiving Brain Radiotherapy

TypeobservationalSponsorJona Hattangadi-GluthRan2015 to 2030Enrolled300ConditionsPrimary Brain Tumor, Glioma, Meningioma, Schwannoma
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Mia SalansDepartment of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California, USA.ORCID 0000-0002-5195-5590
Michelle D TibbsDepartment of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California, USA.
Roshan KarunamuniDepartment of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California, USA.
Anthony YipDepartment of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California, USA.
Minh-Phuong Huynh-LeDepartment of Radiation Oncology, George Washington University, Washington DC, USA.
Anna Christina MacariDepartment of Psychiatry, University of California San Diego, La Jolla, California, USA.
Anny ReyesDepartment of Psychiatry, University of California San Diego, La Jolla, California, USA.
Kathryn TringaleDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Carrie R McDonaldDepartment of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California, USA.
Jona A Hattangadi-GluthDepartment of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California, USA.
University of California San Diego · USGeorge Washington University · USMemorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases: Avoidance of Eloquent White Matter and Hippocampal RegionsR01CA238783 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HATTANGADI-GLUTH, JONA A · 2019 to 2021
$737k
Explaining cognitive heterogeneity in temporal lobe epilepsy (TLE): Identifying unique imaging features, health-related risk factors and protective factors in TLE subtypesF31NS111883 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI REYES, ANNY · 2019 to 2021
$89k
American Cancer Society RSG-15-229-01-CCECTRI 1KL2TR001444HSRD VA TPR 15-229NCATS NIH HHS UL1 TR001442NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA238783NIH HHS 1TL1TR001444NINDS NIH HHS F31 NS111883UC San Diego Moores Cancer Center P30 CA02310029
6 · The paper itself

Abstract

backgroundWe explored fine motor skills (FMS) before and after brain radiotherapy (RT), analyzing associations between longitudinal FMS and imaging biomarkers of cortical and white matter (WM) integrity in motor regions of interest (ROIs).

methodsOn a prospective trial, 52 primary brain tumor patients receiving fractionated brain RT underwent volumetric brain MRI, diffusion tensor imaging, and FMS assessments (Delis-Kaplan Executive Function System Trail Making Test Motor Speed [DKEFS-MS], Grooved Pegboard Dominant Hands [PDH], and Grooved Pegboard Nondominant Hands [PNDH]) at baseline and 3-, 6-, and 12-month post-RT. Motor ROIs autosegmented included: sensorimotor cortices and superficial WM, corticospinal tracts, cerebellar cortices and WM, and basal ganglia. Volume (cc) was measured in all ROIs at each timepoint. Diffusion biomarkers (FA [fractional anisotropy] and MD [mean diffusivity]) were additionally measured in WM ROIs. Linear mixed-effects models assessed biomarkers as predictors of FMS scores. P values were corrected for multiple comparisons.

resultsHigher RT dose was associated with right paracentral cortical thinning (β = -2.42 Gy/(month × mm), P = .03) and higher right precentral WM MD (β = 0.69 Gy/(month × µm2/ms), P = .04). Higher left (β = 38.7 points/(month × µm2/ms), P = .004) and right (β = 42.4 points/(month × µm2/ms), P = .01) cerebellar WM MD, left precentral cortical atrophy (β = -8.67 points/(month × mm), P = .02), and reduced right cerebral peduncle FA (β = -0.50 points/month, P = .01) were associated with worse DKEFS-MS performance. Left precentral cortex thinning was associated with worse PDH scores (β = -17.3 points/(month × mm), P = .02). Left (β = -0.87 points/(month × cm3), P = .001) and right (β = -0.64 points/(month × cm3), P = .02) cerebellar cortex, left pons (β = -19.8 points/(month × cm3), P = .02), and right pallidum (β = -10.8 points/(month × cm3), P = .02) atrophy and reduced right internal capsule FA (β = -1.02 points/month, P = .03) were associated with worse PNDH performance.

conclusionsBiomarkers of microstructural injury in motor-associated brain regions were associated with worse FMS. Dose avoidance in these areas may preserve FMS.

Indexed as

Diffusion Tensor ImagingWhite MatterBiomarkersBrainHumansMotor SkillsProspective StudiesBiomarkersbrain radiationdiffusion tensor imagingfine motor skillsprimary brain tumor

Identifiers

PMID33543265
PMCPMC8328007
OpenAlexW3127414577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.